{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:38:31Z","timestamp":1793122711155,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.diabres.2026.113547","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:37:00Z","timestamp":1788478620000},"page":"113547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From beta-cell stress to tertiary lymphoid structure formation: a stage-dependent framework for interpreting type 1 diabetes progression"],"prefix":"10.1016","volume":"241","author":[{"given":"Tareq Nayef","family":"AlRamadneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Kubaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir Mahmood","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey Kumar","family":"Srivastav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minovarova","family":"Charrazkhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radjabov","family":"Akhtam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113547_b0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00299027","article-title":"Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus","volume":"30","author":"Foulis","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113547_b0015","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/dc13-0604","article-title":"Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment","volume":"37","author":"Orban","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113547_b0020","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/dom.70354","article-title":"Real-world evaluation of teplizumab in type 1 diabetes: progression to insulin requirement","volume":"28","author":"Mahesh","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113547_b0025","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s00125-025-06646-6","article-title":"Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes","volume":"69","author":"Karakus","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2026.113547_b0035","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00125-020-05176-7","article-title":"Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?","volume":"63","author":"Mallone","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117144","article-title":"Spatial transcriptomics from pancreas and local draining lymph node tissue reveals a lymphotoxin-\u03b2 signature in human type 1 diabetes","volume":"45","author":"Medina-Serpas","year":"2026","journal-title":"Cell Rep"},{"key":"10.1016\/j.diabres.2026.113547_b0045","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nri2192","article-title":"Type 1 diabetes as a relapsing-remitting disease?","volume":"7","author":"von Herrath","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.diabres.2026.113547_b0050","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1073\/pnas.071050898","article-title":"Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase","volume":"98","author":"Hiemstra","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diabres.2026.113547_b0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm0798-781","article-title":"Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry","volume":"4","author":"Horwitz","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2026.113547_b0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 Days after SARS-CoV-2 infection among persons aged <18 years - united states, march 1, 2020-june 28, 2021","volume":"71","author":"Barrett","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diabres.2026.113547_b0065","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s42000-025-00662-2","article-title":"The impact of COVID-19 pandemic on the incidence, presentation, and management of type 1 diabetes in children and adolescents: a narrative review","volume":"24","author":"Papapetrou","year":"2025","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.diabres.2026.113547_b0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.diabres.2026.113547_b0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.diabres.2026.113547_b0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0397-289","article-title":"Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus","volume":"15","author":"Vafiadis","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2026.113547_b0085","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41588-019-0524-6","article-title":"The impact of proinflammatory cytokines on the \u03b2-cell regulatory landscape provides insights into the genetics of type 1 diabetes","volume":"51","author":"Ramos-Rodr\u00edguez","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2026.113547_b0090","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/MCB.01259-09","article-title":"Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression","volume":"29","author":"Kang","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.diabres.2026.113547_b0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2010.27","article-title":"Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host","volume":"6","author":"Hober","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2026.113547_b0100","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2337\/db14-1370","article-title":"Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113547_b0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00125-015-3820-4","article-title":"Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes","volume":"59","author":"Krogvold","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06990","article-title":"Differential cell autonomous responses determine the outcome of coxsackievirus infections in murine pancreatic \u03b1 and \u03b2 cells","volume":"4","author":"Marroqui","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.diabres.2026.113547_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116174","article-title":"Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis","volume":"44","author":"Huber","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.diabres.2026.113547_b0120","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","article-title":"A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death","volume":"31","author":"Garg","year":"2012","journal-title":"Embo j"},{"key":"10.1016\/j.diabres.2026.113547_b0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.diabres.2026.113547_b0130","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","article-title":"Conventional and neo-antigenic peptides presented by \u03b2 cells are targeted by circulating na\u00efve CD8+ T cells in type 1 diabetic and healthy donors","volume":"28","author":"Gonzalez-Duque","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2026.113547_b0135","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2337\/db13-1952","article-title":"Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes","volume":"63","author":"McGinty","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113547_b0140","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2337\/db24-0611","article-title":"Novel T-cell reactivities to hybrid insulin peptides in islet autoantibody-positive at-risk individuals","volume":"74","author":"Hohenstein","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113547_b0145","article-title":"The cGAS-STING pathway: a therapeutic target in diabetes and its complications. Burns","volume":"12","author":"He","year":"2024","journal-title":"Trauma"},{"key":"10.1016\/j.diabres.2026.113547_b0150","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-\u03b1 mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0155","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-017-4536-4","article-title":"IFN-\u03b1 induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells","volume":"61","author":"Coomans de Brach\u00e8ne","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155933","article-title":"cGAS suppresses \u03b2-cell proliferation by a STING-independent but CEBP\u03b2-dependent mechanism","volume":"157","author":"Cai","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2026.113547_b0165","first-page":"1650","article-title":"Animal models have little to teach us about type 1 diabetes: 1","volume":"47","author":"Roep","year":"2004","journal-title":"In support of this proposal Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.70224","article-title":"Humanized mouse models for type 1 diabetes","volume":"5","author":"Serreze","year":"2025","journal-title":"Curr Protoc"},{"key":"10.1016\/j.diabres.2026.113547_b0175","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00125-024-06106-7","article-title":"Interferons are key cytokines acting on pancreatic islets in type 1 diabetes","volume":"67","author":"Coomans de Brach\u00e8ne","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134210","article-title":"Implications of the cGAS-STING pathway in diabetes: Risk factors and therapeutic strategies","volume":"278","author":"Mohammadi","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.diabres.2026.113547_b0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2026.113547_b0190","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2337\/db19-0058","article-title":"NIH initiative to improve understanding of the pancreas, islet, and autoimmunity in type 1 diabetes: the human pancreas analysis program (HPAP)","volume":"68","author":"Kaestner","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113547_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pedi.12097","article-title":"The juvenile diabetes research foundation network for pancreatic organ donors with diabetes (nPOD) program: goals, operational model and emerging findings","volume":"15","author":"Pugliese","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2026.113547_b0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7793","article-title":"Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.diabres.2026.113547_b0205","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00125-016-4140-z","article-title":"Insulitis in human diabetes: a histological evaluation of donor pancreases","volume":"60","author":"Lundberg","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113547_b0210","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.2337\/db14-0549","article-title":"Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes","volume":"63","author":"Rodriguez-Calvo","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113547_b0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.diabres.2026.113547_b0220","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/s41467-025-59626-0","article-title":"Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset","volume":"16","author":"Golden","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.diabres.2026.113547_b0225","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.100535","article-title":"The extra-islet pancreas supports autoimmunity in human type 1 diabetes","volume":"13","author":"Barlow","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.diabres.2026.113547_b0230","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fimmu.2016.00430","article-title":"Ectopic lymphoid structures: powerhouse of autoimmunity","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2026.113547_b0235","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/eji.200425830","article-title":"Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis","volume":"35","author":"Manzo","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.diabres.2026.113547_b0240","article-title":"Tertiary lymphoid structures in autoimmune diseases","volume":"14","author":"Dong","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2026.113547_b0245","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.diabres.2026.113547_b0250","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2014.12.006","article-title":"Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4","volume":"41","author":"Wing","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.diabres.2026.113547_b0255","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2026.113547_b0260","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113547_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70063","article-title":"Tertiary lymphoid structures across organs: context, composition, and clinical levers","volume":"335","author":"Guillaume","year":"2025","journal-title":"Immunol Rev"},{"key":"10.1016\/j.diabres.2026.113547_b0270","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","article-title":"Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes","volume":"4","author":"Fasolino","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.diabres.2026.113547_b0275","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine society, and the american diabetes association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113547_b0280","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.2337\/dc14-0893","article-title":"Liraglutide and the preservation of pancreatic \u03b2-cell function in early type 2 diabetes: the LIBRA trial","volume":"37","author":"Retnakaran","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113547_b0285","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.2015.2928","article-title":"Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial","volume":"313","author":"Bonifacio","year":"2015","journal-title":"JAMA"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:27:37Z","timestamp":1793122057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726004675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"alternative-id":["S0168822726004675"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113547","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From beta-cell stress to tertiary lymphoid structure formation: a stage-dependent framework for interpreting type 1 diabetes progression","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113547"}}